Vaibhav Sharma | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Vaibhav Sharma | Medicine and Dentistry | Best Researcher Award

Clinical Observer at St. Louis Heart and Vascular, St. Louis, MO, United States

Vaibhav Sharma is a dedicated medical graduate with a strong foundation in clinical practice and research. With two years of patient care experience, he has developed a keen eye for detailed medical assessments and accurate documentation. His leadership in innovative health screening projects demonstrates his commitment to improving healthcare outcomes. Vaibhav is passionate about advancing medicine through evidence-based practices and interdisciplinary collaboration, combining his expertise in patient care with a drive for continuous learning and research. Aspiring to a respected academic position, he seeks to contribute to healthcare advancement through impactful research and clinical practice, aiming to make a meaningful difference in patient care and medical progress.

Professional Profile

Education

Vaibhav Sharma completed his MBBS from the Armed Forces Medical College (AFMC), Pune, India, from August 2017 to February 2024. He consistently ranked among the top 10% of his class, excelling in subjects like Pharmacology, Microbiology, Ophthalmology, Otorhinolaryngology, and Pediatrics. He has successfully passed USMLE Step 1 and Step 2 CK, achieving a high score of 271 in Step 2 CK, placing him in the 98th percentile. He also holds impressive scores in the TOEFL (115/120) and the Occupational English Test, showcasing his strong command over the English language. His academic background is marked by a solid blend of clinical skills and theoretical knowledge, laying a strong foundation for his future endeavors in the medical field.

Professional Experience

Vaibhav Sharma’s professional journey includes a Visiting Scholar role at the University of Texas Health in Houston, where he immersed himself in advanced heart failure and heart transplant care. His experience extends to an observership at Christian Hospital in St. Louis, Missouri, where he enhanced his understanding of interventional cardiology and electrophysiology. Prior to this, he completed an externship at the Heart and Vascular Institute in Detroit, Michigan, focusing on cardiovascular health management and patient care efficiency. He also served as a Research Analyst at Panscience Innovations, where he led the development of an AI-based software aimed at improving clinical operations. Vaibhav’s clinical internship at Command Hospital, Pune, provided hands-on experience across various specialties, allowing him to contribute to rural health screening projects and develop efficient screening interventions for lifestyle diseases.

Research Interest

Vaibhav Sharma’s research interests lie at the intersection of clinical medicine and innovative health technologies. He is passionate about exploring cardiovascular diseases, particularly focusing on heart failure, arrhythmias, and myocardial conditions. His projects have included screening interventions for hematological abnormalities and lifestyle diseases in rural populations, emphasizing early detection and preventive care. Vaibhav is also interested in the role of lipid profiles in the progression of diabetic retinopathy, as well as the genetic basis of stress-induced ventricular arrhythmias. He aims to integrate emerging technologies, such as AI and machine learning, into clinical research to enhance diagnostic accuracy and treatment outcomes. His research reflects a commitment to advancing evidence-based practices and improving patient care through rigorous scientific inquiry.

Research Skills

Vaibhav Sharma possesses a robust set of research skills that enable him to conduct thorough and impactful studies. He is proficient in designing and executing clinical surveys, as demonstrated in his rural welfare research on myeloma screening and lifestyle disease prevention. His experience includes data collection, statistical analysis, and interpretation of complex clinical data, skills that he has applied in projects such as his lipid profile study on diabetic retinopathy patients. Vaibhav is also skilled in using electronic medical record (EMR) systems like EPIC for research purposes, ensuring accurate data management. Additionally, he has a strong background in preparing manuscripts for publication, contributing to peer-reviewed journals. His ability to collaborate with multidisciplinary teams and present research findings effectively makes him a valuable contributor to the scientific community.

Awards and Honors

Vaibhav Sharma has earned several awards and recognitions throughout his academic and professional journey. He received a prestigious research grant from the Indian Council of Medical Research (ICMR) for his study on the lipid profile in diabetic retinopathy patients. He was also acknowledged by the state government for his rural welfare project, which received a “Mega Project” status and a sponsorship of INR 1,00,00,000. In addition, Vaibhav has been recognized for his academic excellence, consistently ranking in the top 10% of his class at AFMC, Pune, and securing honors in multiple medical disciplines. He has also received accolades for his contributions to clinical presentations, such as his case presentation on bisalbuminemia at the American College of Physicians – India Chapter. His achievements reflect his dedication to medical research, academic excellence, and community-focused healthcare initiatives.

Conclusion

Vaibhav Sharma is a promising candidate for the Best Researcher Award, with strengths in conducting impactful research, receiving grants, and integrating clinical experience with research insights. His strong academic background and contributions to the field of cardiology and community health research are commendable. By focusing on long-term studies, enhancing his publication record, and narrowing his research focus, he can further strengthen his candidacy. His passion for continuous learning and medical advancement makes him a valuable asset to the research community.

Publications Top Notes

  1. SAICR‐CTO: Single Access Impella‐Guided Complete Revascularization in Chronic Total Occlusion—A Novel Approach to High‐Risk PCI
    • Journal: Catheterization and Cardiovascular Interventions
    • Year: 2024-10-22
    • DOI: 10.1002/ccd.31277
    • Contributors: Vaibhav Sharma, Abishek Arokiadoss, Anjali Bhardwaj, Shariq Shamim
  2. Comparison between Amino Acid Profiling of Structural Proteins of Earliest and Recent Omicron Strain of SARS-CoV-2 and Nutritional Burden on COVID-19 Patients
    • Journal: Human Nutrition & Metabolism
    • Year: 2023-12
    • DOI: 10.1016/j.hnm.2023.200220
    • Contributors: Vivek Ambade, Sonia Ambade, Vaibhav Sharma, Prasanna Sanas
  3. Normative Data of Beta-2-Microglobulin and Plasma Proteins from an Agrarian Indian Community By a Door-to-Door Survey: Results of Simple (IMAGe-002B) Study
    • Journal: Blood
    • Year: 2023-11-02
    • DOI: 10.1182/blood-2023-191125
    • Contributors: Yash Vashishth, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair
  4. Prevalence of MGUS in Rural Indian Population: Results of Simple (IMAGe-002A) Study
    • Journal: Blood
    • Year: 2023-11-02
    • DOI: 10.1182/blood-2023-189661
    • Contributors: Celine Raphael, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair

 

 

Isabella Colonna | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Isabella Colonna | Medicine and Dentistry | Best Researcher Award

MD, PhD at ASL Lecce, Ospedale Ferrari – Casarnao, Italy.

Dr. Isabella Colonna, MD, PhD, is a highly skilled neurologist with a deep specialization in epilepsy. She serves as the head of the EEG/Epilepsy Unit at the Neurology Department of “F. Ferrari” Hospital in Casarano, ASL Lecce, Italy. With nine years of experience, Dr. Colonna has significantly contributed to both clinical practice and research in neurology. She has a robust academic background, having earned her medical degree with honors from the University of Rome Tor Vergata, followed by her PhD focusing on neuroimaging in Alzheimer’s Disease. Her involvement with the European Academy of Neurology (EAN) as a representative on the Communication Committee and her role as an EAN Brain Health Ambassador underscore her commitment to advancing neurological health awareness across Europe. Dr. Colonna’s work in promoting brain health and collaboration between neurological societies, political institutions, and patient organizations is widely recognized, positioning her as a leader in the field.

Professional Profile

Education

Dr. Isabella Colonna graduated cum laude in Medicine from the University of Rome Tor Vergata in 2014, achieving a score of 110/110. She further expanded her education through an Erasmus program at the Medical University of Regensburg, Germany, in 2012-2013. After obtaining her medical degree, she pursued a residency in Neurology at the Medical University of Graz, Austria, which she completed in 2021. During her residency, she engaged in clinical training and research, culminating in a PhD with a focus on “Magnetization Transfer Imaging: A Non-Conventional MRI Technique for Longitudinal Assessment of Alzheimer’s Disease.” Recognized for her expertise, Dr. Colonna also earned a Neurosonology Certification from the General Medical Council of Austria in 2021. Additionally, she completed a Master’s degree in Neurophysiology at the Medical University of Bologna from 2023 to 2024, which further strengthened her skills in the field.

Professional Experience

Dr. Isabella Colonna’s professional journey reflects her dedication to clinical neurology and research. Since 2023, she has been leading the EEG/Epilepsy Unit at the “F. Ferrari” Hospital in Casarano, ASL Lecce, Italy. Prior to this role, she served as a neurologist in various hospitals across Southern Italy, including the “A. Perrino” Hospital in Brindisi and the IRCCS Maugeri di Bari, where she gained extensive experience in treating neurological disorders. From 2015 to 2021, Dr. Colonna was a neurology resident at the Medical University of Graz, Austria, where she honed her skills in neuroimaging and patient care. During this time, she also served as a teaching assistant at the university, sharing her knowledge with students. Her professional experience extends to her involvement with the European Academy of Neurology (EAN), where she has played a key role in communication efforts and advocacy for brain health.

Research Interest

Dr. Isabella Colonna’s research interests are centered on advancing the understanding of neurological disorders, particularly through neuroimaging and epilepsy research. Her PhD research focused on “Magnetization Transfer Imaging” as a method for tracking changes in Alzheimer’s disease over time, highlighting her interest in non-conventional MRI techniques. Her work aims to improve the diagnosis and management of Alzheimer’s and other neurodegenerative conditions through advanced imaging methods. Additionally, she is passionate about improving patient outcomes in epilepsy, which aligns with her current role as the head of the EEG/Epilepsy Unit at “F. Ferrari” Hospital. Dr. Colonna is also deeply committed to brain health awareness and policy-making, as evidenced by her involvement in the European Academy of Neurology’s (EAN) initiatives. Her research contributions, such as a recent study on the role of neurological societies in promoting brain health in Europe, underscore her dedication to bridging clinical practice with innovative research.

Research Skills

Dr. Isabella Colonna possesses a diverse set of research skills that have contributed to her success in the field of neurology. She is proficient in advanced neuroimaging techniques, including Magnetization Transfer Imaging (MTI), which she utilized during her PhD research to study Alzheimer’s disease progression. Her expertise extends to neurophysiology, as evidenced by her leadership of the EEG/Epilepsy Unit at “F. Ferrari” Hospital, where she applies her skills in electroencephalography (EEG) for the diagnosis and management of epilepsy. Dr. Colonna is also experienced in conducting clinical research, having completed multiple projects that have led to publications in reputable journals. Her work with the European Academy of Neurology (EAN) has further developed her skills in survey-based research, focusing on brain health awareness. Additionally, she has experience as a reviewer and abstract evaluator for the EAN, contributing her expertise to the advancement of neurological research.

Awards and Honors

Throughout her career, Dr. Isabella Colonna has received numerous awards and honors, reflecting her outstanding contributions to the field of neurology. In 2019, she was awarded the “Young Investigator Award” by the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft) for her research on neuroimaging in Alzheimer’s disease. The same year, she received a bursary from the European Academy of Neurology (EAN) for her participation in the 5th EAN Congress in Oslo, Norway. Dr. Colonna’s commitment to advancing brain health awareness was further recognized in 2024, when she was named an EAN “Brain Health Ambassador.” Her involvement with the EAN also includes roles as a representative on the eCommunication Board and Communication Committee, where she has contributed to shaping the dialogue around neurological health. These accolades highlight her leadership, expertise, and dedication to improving neurological care and research on both national and European levels.

Conclusion

Isabella Colonna is a strong candidate for the Best Researcher Award. Her contributions to neurology, particularly in neuroimaging and epilepsy, her active involvement in professional societies, and her research accomplishments make her well-suited for this recognition. Strengthening her international collaborations and focusing on innovation could further bolster her profile for such prestigious awards.

Publications Top Notes

  1. Cortical laminar necrosis due to hypoglycemia in anti-CV2/CRMP5 paraneoplastic encephalitis: a curious association
    • Authors: Altomare, S., Colonna, I., Leone, R., Giorelli, M.
    • Year: 2024
    • Citations: 0
    • Journal: Acta Neurologica Belgica, 124(4), pp. 1405–1408.
  2. Sex steroid hormones and epilepsy: Effects of hormonal replacement therapy on seizure frequency of postmenopausal women with epilepsy—A systematic review
    • Authors: Carvalho, V., Colonna, I., Curia, G., Vonck, K., Zedde, M.
    • Year: 2023
    • Citations: 2
    • Journal: European Journal of Neurology, 30(9), pp. 2884–2898.
  3. Bringing door-to-needle times within the European benchmarks results in better stroke patients outcomes in a spoke hospital from the Apulian Region
    • Authors: Giorelli, M., Leone, R., Aniello, M.S., Tatò, E., Scelzi, A.
    • Year: 2023
    • Citations: 1
    • Journal: Neurological Sciences, 44(9), pp. 3199–3207.
  4. Serum levels of IL-6 are associated with cognitive impairment in the salus in apulia population-based study
    • Authors: Griseta, C., Battista, P., Castellana, F., Minafra, B., Sardone, R.
    • Year: 2023
    • Citations: 6
    • Journal: Heliyon, 9(3), e13972.
  5. Clinico-genetic spectrum of limb-girdle muscular weakness in Austria: A multicentre cohort study
    • Authors: Krenn, M., Tomschik, M., Wagner, M., Löscher, W.N., Cetin, H.
    • Year: 2022
    • Citations: 4
    • Journal: European Journal of Neurology, 29(6), pp. 1815–1824.
  6. Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score—a prospective observational study
    • Authors: Kneihsl, M., Bisping, E., Scherr, D., Enzinger, C., Gattringer, T.
    • Year: 2022
    • Citations: 22
    • Journal: European Journal of Neurology, 29(1), pp. 149–157.
  7. Microstructural tissue changes in Alzheimer disease brains: Insights from magnetization transfer imaging
    • Authors: Colonna, I., Koini, M., Pirpamer, L., Schmidt, R., Ropele, S.
    • Year: 2021
    • Citations: 6
    • Journal: American Journal of Neuroradiology, 42(4), pp. 688–693.
  8. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer’s disease patients: a retrospective observational study
    • Authors: Scaricamazza, E., Colonna, I., Sancesario, G.M., Mercuri, N.B., Liguori, C.
    • Year: 2019
    • Citations: 30
    • Journal: Neurological Sciences, 40(7), pp. 1377–1382.
  9. Cognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure
    • Authors: Frey, A., Sell, R., Homola, G.A., Störk, S., Stoll, G.
    • Year: 2018
    • Citations: 74
    • Journal: JACC: Heart Failure, 6(7), pp. 583–592.
  10. Abnormal blood flow on transcranial duplex sonography predicts poor outcome after stroke thrombectomy
    • Authors: Kneihsl, M., Niederkorn, K., Deutschmann, H., Fazekas, F., Gattringer, T.
    • Year: 2018
    • Citations: 18
    • Journal: Stroke, 49(11), pp. 2780–2782.

 

Ting-Ting Chang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Ting-Ting Chang l Medicine and Dentistry l Best Researcher Award

Associate Professor at National Yang Ming Chiao Tung University, Taiwan

Dr. Ting-Ting Chang is an Associate Professor at National Yang Ming Chiao Tung University, specializing in vascular medicine, kidney disease, diabetes, and new drug development. With a Ph.D. from National Yang-Ming University, Dr. Chang has a robust publication record in high-impact journals, including Science Translational Medicine and Angiogenesis. Recognized with awards such as the Young Scientists Award and the Young Investigator Fellowship, Dr. Chang is also a full member of Sigma Xi and other prestigious societies. Their research is notable for its innovation and significant contributions to understanding and treating complex diseases.

Profile:

Education

Ting-Ting Chang, Ph.D., earned her Ph.D. in Pharmacology from National Yang-Ming University in Taipei, Taiwan, in 2015. Her educational journey is distinguished by her continued academic and research excellence, which laid a strong foundation for her current role as an Associate Professor in the Department and Institute of Pharmacology at National Yang Ming Chiao Tung University. Prior to this, Dr. Chang completed her post-doctoral research at the same institution, further solidifying her expertise in pharmacology and related fields.

Professional Experience

Ting-Ting Chang, Ph.D., is an accomplished researcher and academic with extensive experience in the field of pharmacology. Currently serving as an Associate Professor at the Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Dr. Chang has previously held roles as an Assistant Professor and Post-doctoral Researcher at the same institution. Their career spans significant contributions to vascular medicine, kidney disease, diabetes, and new drug development, with a track record of high-impact research and numerous publications in leading scientific journals.

Research Interest

Ting-Ting Chang’s research interests encompass a broad range of topics within vascular medicine and molecular biology, focusing on the mechanisms underlying vascular dysfunction, kidney disease, and diabetes mellitus. Her work includes experimental animal model design and new drug development, aiming to uncover novel therapeutic targets and strategies for these critical health issues. Dr. Chang’s research integrates molecular and cellular approaches to address complex pathological conditions, contributing significantly to advancements in understanding and treating vascular and metabolic disorders.

Research Skills

Ting-Ting Chang, Ph.D., demonstrates exceptional research skills through a robust portfolio of high-impact publications and significant contributions to fields such as vascular medicine, kidney disease, and diabetes. With a strong academic background and extensive experience as both an Associate Professor and Post-doctoral Researcher, Dr. Chang excels in designing and conducting innovative studies, particularly in identifying novel therapeutic targets and mechanisms. Their proficiency in experimental animal model design and new drug development further highlights their expertise, while their membership in prestigious scientific societies and receipt of notable awards underscore their recognition and influence in the research community.

Award and Recognition

Ting-Ting Chang, Ph.D., has garnered significant awards and recognition throughout their career, underscoring their outstanding contributions to research. Notably, Dr. Chang received the Young Scientists Award at the 55th Annual Scientific Meeting of the Japan Atherosclerosis Society in 2023 and the Young Investigator Fellowship Award at the 88th European Atherosclerosis Society Congress in 2020. In addition, Dr. Chang was awarded full membership of Sigma Xi in 2023, reflecting their esteemed position in the scientific community and their impactful research in vascular medicine, kidney disease, and diabetes.

Conclusion

Ting-Ting Chang, Ph.D., is a highly qualified candidate for the Best Researcher Award. Their exceptional contributions to vascular medicine, kidney disease, and diabetes, along with a strong publication record and recognition in the scientific community, underscore their suitability for this award. Addressing areas for improvement, such as expanding research applications and increasing public engagement, could further enhance their profile as a leading researcher. Overall, Dr. Chang’s dedication, innovative research, and professional achievements make them an excellent contender for the Best Researcher Award.

Publication Top Notes

  • Association between vitiligo and risk of retinal detachment: a population-based cohort study in Taiwan
    • Authors: Chen, C.-L., Wu, C.-Y., Chen, Y.-L., Chang, Y.-T., Wu, C.-Y.
    • Year: 2024
    • Citations: 0
  • Rejuvenation of the dorsal hand by injectable poly-D, L-lactic acid: A pilot study
    • Authors: Ma, S.-H., Lin, C.-Y., Lin, J.-Y., Chang, Y.-T., Chen, C.-C.
    • Year: 2024
    • Citations: 0
  • Correlation of Disease Severity, Proinflammatory Cytokines, and Reduced Brain Gray Matter Volumes in Patients with Atopic Dermatitis
    • Authors: Li, C.-Y., Chang, W.-C., Chen, M.-H., Chen, Y.-Y., Bai, Y.-M.
    • Year: 2024
    • Citations: 0
  • Risk of Type 1 Diabetes Mellitus in Patients with Atopic Dermatitis: A Nationwide Population-Based Cohort Study
    • Authors: Li, M.-C., Wu, C.-Y., Chang, Y.-T., Lyu, Y.-S., Wu, C.-Y.
    • Year: 2023
    • Citations: 0
  • Assoziation zwischen chronischer Nierenerkrankung und dem Risiko für bullöses Pemphigoid: eine nationale bevölkerungsbasierte Kohortenstudie
    • Authors: Yu, W.-T., Ma, S.-H., Wu, C.-Y., Chang, Y.-T., Wu, C.-Y.
    • Year: 2023
    • Citations: 1